Intravenous Opdivo, with $2.48 billion in sales, topped the list of precision oncology products in BMS's growth portfolio.

Bristol Myers Squibb will make even deeper cuts to its organization to enhance efficiencies as it faces the 2028 loss of ...

The 4-factor dividend growth portfolio is a strategy that leverages stock selection process of SCHD with a few minor twists.

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Armenian-American producer Armen Zabounian, known professionally as Peyote Beats, has won a Grammy Award for his work on ...